Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 57 | 58 | 23 | 0 | 0 |
| Gross Profit | 57 | 58 | 23 | N/A | N/A |
| Operating Expenses | 1,549 | 1,957 | 2,262 | 2,006 | 2,476 |
| Operating Income | -1,492 | -1,899 | -2,239 | -1,991 | -2,476 |
| Other Income | -1 | -2 | 0 | -11 | 0 |
| Pre-tax Income | -1,493 | -1,901 | -2,239 | -2,002 | -2,476 |
| Net Income Continuous | -1,493 | -1,901 | -2,239 | -2,002 | -2,476 |
| Net Income | $-1,493 | $-1,901 | $-2,239 | $-2,002 | $-2,476 |
| EPS Basic Total Ops | -2,018.59 | -2,731.04 | -5,343.33 | -4,155.92 | -6,233.89 |
| EPS Basic Continuous Ops | -2,027.91 | -2,751.41 | -5,330.00 | -4,062.54 | -6,252.70 |
| EPS Diluted Total Ops | -2,018.59 | -2,731.04 | -5,343.33 | -4,155.92 | -6,233.89 |
| EPS Diluted Continuous Ops | -2,027.91 | -2,751.41 | -5,330.00 | -4,062.54 | -6,252.70 |
| EBITDA(a) | $-1,472 | $-1,878 | $-2,219 | $-1,984 | $-2,455 |